ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 751 filers reported holding ASTRAZENECA PLC in Q1 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $667 | -94.7% | 9,850 | -94.4% | 0.01% | -95.4% |
| Q2 2023 | $12,480 | +26.7% | 174,381 | +22.8% | 0.31% | +90.1% |
| Q1 2023 | $9,853 | +37.0% | 141,958 | +33.8% | 0.16% | -16.6% |
| Q4 2022 | $7,193 | -98.5% | 106,096 | +1337.8% | 0.19% | +1508.3% |
| Q2 2022 | $488,000 | -71.7% | 7,379 | -71.6% | 0.01% | -74.5% |
| Q1 2022 | $1,725,000 | -3.1% | 25,996 | -15.0% | 0.05% | -7.8% |
| Q4 2021 | $1,781,000 | -11.2% | 30,579 | -8.5% | 0.05% | -41.4% |
| Q3 2021 | $2,006,000 | +3.6% | 33,404 | +3.3% | 0.09% | +45.0% |
| Q2 2021 | $1,937,000 | +20.5% | 32,337 | 0.0% | 0.06% | -6.2% |
| Q1 2021 | $1,608,000 | +122.4% | 32,337 | +123.5% | 0.06% | +156.0% |
| Q4 2020 | $723,000 | -67.2% | 14,466 | -64.0% | 0.02% | -79.3% |
| Q3 2020 | $2,202,000 | +132.5% | 40,177 | +89.1% | 0.12% | +86.2% |
| Q3 2019 | $947,000 | -49.0% | 21,242 | -61.0% | 0.06% | -79.9% |
| Q2 2017 | $1,858,000 | – | 54,500 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |